Classement en actions
#35930
EXMceuticals Inc. specializes in the development and manufacturing of... EXMceuticals Inc. specializes in the development and manufacturing of cannabinoid-derived formulations. The company's primary focus is to match natural, bioactive compounds extracted from the cannabis plant with the specific needs of the nutraceutical, cosmeceutical, therapeutic, and pharmaceutical industries. They produce CBD, a non-intoxicating cannabinoid recognized for its effectiveness against ailments such as acne, anxiety, depression, epilepsy, and neurodegenerative conditions like Parkinson's. Additionally, they produce THC, a psychoactive cannabinoid proven beneficial for pain management, appetite stimulation, anxiety relief, and mitigating chemotherapy side effects. Founded in 2008, the company's head office is located in Quebec, Canada.
Prix de l'action
$0.14814266
Dernière synchronisation: 2023-05-23
Capitalisation boursière
$3.27M
Changement (1 jour)
-0.04%
Échange EXMceuticals Inc. (EXM)
Le prix EXM avec la capitalisation boursière de B
Capitalisation boursière de EXMceuticals Inc.(EXM)
Capitalisation boursière: $3.27M
En August 2026, EXMceuticals Inc. a une capitalisation boursière de $3.27M. Cela fait de EXMceuticals Inc. la 35930th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de EXMceuticals Inc. du 2010 au 2026
EXM par rapport au top 5 des plus populaires stocks
| Prix pour EXM |
|
L’actif B |
La capitalisation boursière de B |
Résultats |
|
|
|
|
$5.452T
|
+166,879,724.57%
|
|
|
|
|
$4.490T
|
+137,437,896.44%
|
|
|
|
|
$4.162T
|
+127,409,768.88%
|
|
|
|
|
$3.676T
|
+112,531,496.75%
|
|
|
|
|
$2.833T
|
+86,718,375.12%
|
